Insider sale
GRACELL BIOTECHNOLOGIES INC.
$1.75M
305.75K shares
What this filing means
ORBIMED ADVISORS LLC plans to sell 305.75K shares of GRACELL BIOTECHNOLOGIES INC. valued at approximately $1.75M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/15/2023ACC: 0000947871-23-000680
305.75K
Shares to sell
$1.75M
Approx. market value
305.75K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Private placement
Cash
10/14/2020
305.75KTotal acquired305.75K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
10/14/2020 | Private placement Cash | 305.75K | — |
| Total | 305.75K | ||
Planned & Completed Dispositions1
Nasdaq Stock MarketPlanned
Units to sell
305.75K
Market value
$1.75M
6/15/2023
Total
Units
305.75K
Value
$1.75M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
6/15/2023 | 305.75K | $1.75M | Nasdaq Stock Market | Planned |
| Total | 305.75K | $1.75M | ||